Veraxa Biotech AG Warrants (VRXAW)

• Market cap: $398K
• Sector: Healthcare
• Industry: Biotechnology

About: Veraxa Biotech Holding AG focus on antibody therapies in medicine. The Company is an oncology-focused biotechnology Company with a clinical program in acute myeloid leukemia and two proprietary platform technologies that enable the development of new generations of antibody drug conjugates (ADC's) and T cell engagers. The Company operates in one reportable segment, focused on the research and development of products for the aging population.